Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
Status:
Terminated
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether combining ganetespib (STA-9090) with
docetaxel is more effective than docetaxel alone in the treatment of subjects with advanced
non-small cell lung cancer.